 | |
| Clinical data | |
|---|---|
| Trade names | Emrok O |
| Routes of administration | Oral |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C22H26FN3O5 |
| Molar mass | 431.464 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Alalevonadifloxacin (trade name Emrok O) is an antibiotic of the fluoroquinolone class.[1] It is a prodrugoflevonadifloxacin with increased oral bioavailability.[2] In India, it is approved for the treatment of infections with Gram-positive bacteria.[3]
|
| |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Antifolates (inhibit bacterial purine metabolism, thereby inhibiting DNA and RNA synthesis) |
| ||||||||||||||||
| Quinolones (inhibit bacterial topoisomerase and/or DNA gyrase, thereby inhibiting DNA replication) |
| ||||||||||||||||
| Anaerobic DNA inhibitors |
| ||||||||||||||||
| RNA synthesis |
| ||||||||||||||||
| |||||||||||||||||
 | This systemic antibiotic-related article is a stub. You can help Wikipedia by expanding it. |
